ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕

Archives

  • Home
  • Archives

Archive By Category

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Archive By Month

  • February 2026
  • November 2025
  • July 2025
  • May 2025
  • January 2025
  • September 2024
  • July 2024
  • March 2024
  • January 2024
  • October 2023
  • July 2023
  • March 2023
  • January 2023
  • September 2022
  • June 2022
  • March 2022
  • December 2021
  • September 2021
  • June 2021
  • March 2021
  • October 2020
  • June 2020
  • February 2020
  • October 2019

Archive By Tag

Advocacy Anal cancer Artificial intelligence (AI) Bladder cancer Brain cancer Breast cancer Colorectal cancer ComboMATCH Esophagus cancer Gallbladder cancer Head and neck cancer Health equity Immunotherapy In memory Kidney cancer Leukemia Liver cancer Lung cancer Lymphoma Mammography Melanoma Myelodysplastic syndrome Myeloma NCI-MATCH Older adults Pancreatic cancer Pancreatic cysts Patient-reported outcomes Patient education Patient navigation Penis cancer Personalized treatment Policy Precision medicine Prevention Prostate cancer Real-world data/evidence Research results Sarcoma Screening for cancer Side effects Survivorship Targeted therapy Upper tract urothelial cancer Young adults


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc